X0607 3 2026-10-05 0 0001901279 Nayax Ltd. NYAX 0002161738 Orenstein Moshe true ARIK EINSTEIN 3 HERZLIYA L3 4659071 ISRAEL 0 1 0 0 CCO Ordinary Shares 4325 D Ordinary Shares 3032 D Ordinary Shares 953 D Ordinary Shares 1049 D Ordinary Shares 1623 D Ordinary Shares 10000 D Stock Option (Right to Buy) 38.1074 2022-11-17 2027-02-17 Ordinary Shares 5000 D Stock Option (Right to Buy) 38.1074 2024-09-30 2027-02-17 Ordinary Shares 5000 D The shares are held on the Tel Aviv Stock Exchange. The Reporting Person was granted 953 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 302 RSUs are vested, and the remaining 651 RSUs vest in three equal quarterly installments beginning on December 26, 2026 and ending on June 26, 2027, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. The Reporting Person was granted 1,049 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 174 RSUs are vested, and the remaining 875 RSUs vest in seven equal quarterly installments beginning on December 25, 2026 and ending on June 25, 2028, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. The Reporting Person was granted 1,623 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 355 RSUs are vested, and the remaining 1,268 RSUs vest in eleven equal quarterly installments beginning on December 3, 2026 and ending on June 3, 2029, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. The Reporting Person was granted 10,000 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 2,000 RSUs vest on March 15, 2027, and the remaining 8,000 RSUs vest in four equal annual installments over the following four years, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. The Stock Options are Fully vested and immediately exercisable The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. The Reporting Person holds 5,000 stock options to purchase ordinary shares of Nayax Ltd. (the "Company"). Of these options, 4,500 are vested and currently exercisable, and the remaining 500 options will vest on December 31, 2026, subject to the Reporting Person's continued service to the Company or its subsidiaries through such date. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. This Form 3 is being filed to report the Reporting Person beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934. /s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact 2026-10-30